盐酸布帕西布，Buparlisib Hydrochloride；≥99% (HPLC)

General description

一种脂质类激酶的泛素I类PI3K（磷脂酰肌醇3-激酶）抑制剂，作用于p110α、p110β、p110δ和p110γ，IC50分别为52nM、166nM、116nM和262nM。

Buparlisib is an orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antineoplastic activity. PI3K inhibitor BKM120 specifically inhibits class I PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway in an ATP-competitive manner, thereby inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate and activation of the PI3K signaling pathway。

Buparlisib是泛I类磷脂酰肌醇3-激酶（PI3K）家族的具有潜在抗肿瘤活性的口服生物利用型特定口服抑制剂。 PI3K抑制剂BKM120以ATP竞争的方式特异性抑制PI3K / AKT激酶（或蛋白激酶B）信号传导途径中的I类PIK3，从而抑制次级信使磷脂酰肌醇-3,4,5-三磷酸的产生以及其活化。 PI3K信号通路。

安全信息